These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 16770242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL, Zang YJ, Chen XG, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF, Delgado M, Martinez SM, Abdulkader I, Potel J, Tome S, Otero E, Varo E.
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [Abstract] [Full Text] [Related]

  • 12. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, Greig PD, Grant DR.
    Transplantation; 2006 Jun 27; 81(12):1633-9. PubMed ID: 16794527
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis.
    Marui Y, McCall J, Gane E, Holden A, Duncan D, Yeong ML, Chow K, Munn S.
    N Z Med J; 2005 Jun 24; 118(1217):U1532. PubMed ID: 15980906
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul 24; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.
    Surgery; 2007 May 24; 141(5):598-609. PubMed ID: 17462459
    [Abstract] [Full Text] [Related]

  • 20. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 24; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.